The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAstrazeneca Share News (AZN)

Share Price Information for Astrazeneca (AZN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 12,050.00
Bid: 12,038.00
Ask: 12,040.00
Change: 0.00 (0.00%)
Spread: 2.00 (0.017%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 12,050.00
AZN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

UPDATE 2-Taiwan says in talks with Pfizer and J&J, and Japan considering donating vaccines

Thu, 03rd Jun 2021 08:45

* China's vaccine diplomacy hampering Taiwan, says minister

* German govt helping Taiwan's talks with Pfizer partner
BioNTech

* Japan "seriously and positively" considering donating
shots

* Taiwan infections spike, some 3% of population vaccinated
(Releads)

By Ju-min Park and Mari Saito

TOKYO, June 3 (Reuters) - Taiwan is in talks with COVID-19
vaccine makers like Pfizer and Johnson and Johnson
for more supplies, its foreign minister said on Thursday
while expressing appreciation to Japan for considering donating
much needed shots.

Taiwan has been a model for how to control the pandemic, but
a recent spike in domestic infections has increased the need to
inoculate people faster.

During a video call with international media in Japan,
Foreign Minister Joseph Wu repeated complaints that China, which
claims the island as its own territory, has hampered efforts to
secure more vaccines, and kept Taiwan excluded from the World
Health Organisation.

So far, Taiwan has received only the Moderna Inc
and AstraZeneca Plc vaccines. But Wu said his government
was "negotiating with individual companies like Pfizer" and J&J,
while expressing confidence in its domestic vaccine rollout.

"When and if our own vaccines are rolled out toward the end
of July, I think this will become the most important supply for
the vaccine demand here in Taiwan," Wu said.

Johnson & Johnson was not immediately available for comment.

Responding to Reuters request for comment, Pfizer said: "As
Taiwan is outside the scope of Pfizer’s COVID-19 vaccine
collaboration agreement with BioNTech, we will have to refer you
to BioNTech for any questions on this matter."

BioNTech did not immediately respond to a request for
comment.

Wu did confirm, however, that the German government has
helped with talks underway between Taiwan and BioNTech SE
, after a deal fell through earlier this year.

Taiwan had blamed China for blocking that deal. Beijing,
which has offered to supply Chinese-made vaccines as well as
BioNTech shots via the German firm's Chinese partner Shanghai
Fosun Pharmaceutical Group Co Ltd, has denied that
accusation.

Wu also cited Japanese Foreign Minister Toshimitsu Motegi as
saying that Japan is "seriously and positively" considering
donating vaccines to Taiwan.

"Taiwan and Japan are always very good partners. And in
times of difficulties, we always try to reach out to each
other," he said.

Some 3% of Taiwan's 23.5 million people have been
inoculated, and the government has been scrambling to ensure the
millions of vaccines it has ordered arrive on time amid global
shortages.
(Reporting by Ju-min Park and Mari Saito; Additional reporting
by Ben Blanchard in Taipei; Editing by Christian Schmollinger &
Simon Cameron-Moore)

More News
Today 07:46

AstraZeneca completes collaboration and investment deal with Cellectis

(Alliance News) - AstraZeneca PLC on Monday said it has completed an equity investment in clinical-stage biotechnology company Cellectis, first announced in November.

Read more
3 May 2024 12:17

CORRECT: Angle shares up on assay development deal with AstraZeneca

(Correcting company name in headline)

Read more
3 May 2024 11:50

Angle shares up on assay development deal with AstraZenaca

(Alliance News) - Shares in Angle PLC jumped on Friday, after the company said it has been chosen to develop a prostate cancer assay using its Parsortix technology, opening the door for future clinical study-supporting contracts.

Read more
3 May 2024 07:50

LONDON BRIEFING: InterContinental Hotels makes first-quarter progress

(Alliance News) - London's FTSE 100 is called to open higher on Friday, on the expectation of a softer US jobs report, which could take some sting out of hawkish Federal Reserve interest rate expectations.

Read more
2 May 2024 10:04

AstraZeneca notes positive trial results for Calquence treatment

(Alliance News) - AstraZeneca PLC on Thursday said it observed positive high-level results in the Echo phase 3 trial of its Calquence treatment for previously untreated adult patients with mantle cell lymphoma.

Read more
2 May 2024 07:45

AstraZeneca reports positive results from blood cancer drug trial

(Sharecast News) - AstraZeneca has reported positive results from the use of its Calquence drug in a clinical trial to treat a rare type of blood cancer.

Read more
29 Apr 2024 22:52

J&J, Bristol Myers lose challenges to US drug price negotiation program

April 29 (Reuters) - A U.S. judge on Monday rejected a challenge by Bristol Myers Squibb and Johnson & Johnson to a law requiring them to negotiate the prices of their blockbuster blood clot prevention drugs with the U.S government's Medicare health insurance program or pay heavy penalties.

Read more
29 Apr 2024 10:02

LONDON BROKER RATINGS: Deutsche Bank likes Frasers; Barclays cuts JD

(Alliance News) - The following London-listed shares received analyst recommendations Monday morning and Friday:

Read more
29 Apr 2024 09:13

AstraZeneca makes progress with Truqap and Enhertu cancer treatments

(Alliance News) - AstraZeneca PLC on Monday said its Truqap drug has been recommended for approval in the EU to treat a form of breast cancer, while also noting trial results for its Enhertu offering.

Read more
29 Apr 2024 07:50

LONDON BRIEFING: Hipgnosis Songs Fund backs new Blackstone bid

(Alliance News) - London's FTSE 100 is called to open higher on Monday, with heady gains for US tech stocks on Friday brightening the mood in Europe and Asia at the start of the new week.

Read more
29 Apr 2024 07:24

AstraZeneca makes progress with two breast cancer treatments

(Sharecast News) - AstraZeneca issued favourable updates on two of its breast cancer treatments on Monday - 'Truqap', or capivasertib, and 'Enhertu', or trastuzumab deruxtecan - following encouraging results from respective phase three trials.

Read more
26 Apr 2024 09:33

LONDON BROKER RATINGS: Peel Hunt cuts ConvaTec to 'reduce'

(Alliance News) - The following London-listed shares received analyst recommendations Friday morning:

Read more
25 Apr 2024 16:57

LONDON MARKET CLOSE: FTSE 100 shakes off red-hot US inflation gauge

(Alliance News) - London's FTSE 100 outperformed on Thursday, enjoying a solid rise on largely well-received corporate earnings and a share price jump for miner Anglo American after it received a takeover bid from peer BHP.

Read more
25 Apr 2024 15:14

London close: Stocks finish mixed as US GDP growth slows

(Sharecast News) - London's stock markets finished with a mixed performance on Thursday, as investors digested a slower-than-expected GDP growth reading from the United States, while a slew of well-received earnings underpinned the top-flight index.

Read more
25 Apr 2024 11:50

LONDON MARKET MIDDAY: FTSE 100 hits high on offer for Anglo American

(Alliance News) - The FTSE 100 was outperforming European markets at midday on Thursday, with the index boosted to a record high thanks to takeover talks.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.